This report contains market size and forecasts of Crude Heparin in China, including the following market information:
China Crude Heparin Market Revenue, 2016-2021, 2022-2027, ($ millions)
China Crude Heparin Market Sales, 2016-2021, 2022-2027, (MT)
China top five Crude Heparin companies in 2020 (%)
The global Crude Heparin market size is expected to growth from US$ 3585.3 million in 2020 to US$ 6466.7 million by 2027; it is expected to grow at a CAGR of 8.8% during 2021-2027.
The China Crude Heparin market was valued at US$ XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period.
QYResearch has surveyed the Crude Heparin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
China Crude Heparin Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (MT)
China Crude Heparin Market Segment Percentages, By Type, 2020 (%)
Pig Intestine Mucosa Heparin
Bovine Heparin and Others
China Crude Heparin Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (MT)
China Crude Heparin Market Segment Percentages, By Application, 2020 (%)
Unfractionated Heparin (UFH)
Low-Molecular-Weight Heparin (LMWH)
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Crude Heparin revenues in China market, 2016-2021 (Estimated), ($ millions)
Key companies Crude Heparin revenues share in China market, 2020 (%)
Key companies Crude Heparin sales in China market, 2016-2021 (Estimated), (MT)
Key companies Crude Heparin sales share in China market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bioiberica
Shenzhen Hepalink
Sanofi
Nanjing King-friend
Fengrun Biological Technology
Aspen Oss
Hebei Changshan Biochemical
Changzhou Qianhong
Hepac (Darling Ingredients)
Huaian MDC Pharmaceutical
Yantai Dongcheng Biochemicals
China Crude Heparin Market Revenue, 2016-2021, 2022-2027, ($ millions)
China Crude Heparin Market Sales, 2016-2021, 2022-2027, (MT)
China top five Crude Heparin companies in 2020 (%)
The global Crude Heparin market size is expected to growth from US$ 3585.3 million in 2020 to US$ 6466.7 million by 2027; it is expected to grow at a CAGR of 8.8% during 2021-2027.
The China Crude Heparin market was valued at US$ XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period.
QYResearch has surveyed the Crude Heparin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
China Crude Heparin Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (MT)
China Crude Heparin Market Segment Percentages, By Type, 2020 (%)
Pig Intestine Mucosa Heparin
Bovine Heparin and Others
China Crude Heparin Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (MT)
China Crude Heparin Market Segment Percentages, By Application, 2020 (%)
Unfractionated Heparin (UFH)
Low-Molecular-Weight Heparin (LMWH)
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Crude Heparin revenues in China market, 2016-2021 (Estimated), ($ millions)
Key companies Crude Heparin revenues share in China market, 2020 (%)
Key companies Crude Heparin sales in China market, 2016-2021 (Estimated), (MT)
Key companies Crude Heparin sales share in China market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bioiberica
Shenzhen Hepalink
Sanofi
Nanjing King-friend
Fengrun Biological Technology
Aspen Oss
Hebei Changshan Biochemical
Changzhou Qianhong
Hepac (Darling Ingredients)
Huaian MDC Pharmaceutical
Yantai Dongcheng Biochemicals
1 Introduction to Research & Analysis Reports
1.1 Crude Heparin Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Crude Heparin Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Crude Heparin Overall Market Size
2.1 China Crude Heparin Market Size: 2021 VS 2027
2.2 China Crude Heparin Revenue, Prospects & Forecasts: 2016-2027
2.3 China Crude Heparin Sales: 2016-2027
3 Company Landscape
3.1 Top Crude Heparin Players in China Market
3.2 Top China Crude Heparin Companies Ranked by Revenue
3.3 China Crude Heparin Revenue by Companies
3.4 China Crude Heparin Sales by Companies
3.5 China Crude Heparin Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Crude Heparin Companies in China Market, by Revenue in 2020
3.7 Manufacturers Crude Heparin Product Type
3.8 Tier 1, Tier 2 and Tier 3 Crude Heparin Players in China Market
3.8.1 List of Tier 1 Crude Heparin Companies in China
3.8.2 List of Tier 2 and Tier 3 Crude Heparin Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Crude Heparin Market Size Markets, 2021 & 2027
4.1.2 Pig Intestine Mucosa Heparin
4.1.3 Bovine Heparin and Others
4.2 By Type - China Crude Heparin Revenue & Forecasts
4.2.1 By Type - China Crude Heparin Revenue, 2016-2021
4.2.2 By Type - China Crude Heparin Revenue, 2022-2027
4.2.3 By Type - China Crude Heparin Revenue Market Share, 2016-2027
4.3 By Type - China Crude Heparin Sales & Forecasts
4.3.1 By Type - China Crude Heparin Sales, 2016-2021
4.3.2 By Type - China Crude Heparin Sales, 2022-2027
4.3.3 By Type - China Crude Heparin Sales Market Share, 2016-2027
4.4 By Type - China Crude Heparin Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Crude Heparin Market Size, 2021 & 2027
5.1.2 Unfractionated Heparin (UFH)
5.1.3 Low-Molecular-Weight Heparin (LMWH)
5.2 By Application - China Crude Heparin Revenue & Forecasts
5.2.1 By Application - China Crude Heparin Revenue, 2016-2021
5.2.2 By Application - China Crude Heparin Revenue, 2022-2027
5.2.3 By Application - China Crude Heparin Revenue Market Share, 2016-2027
5.3 By Application - China Crude Heparin Sales & Forecasts
5.3.1 By Application - China Crude Heparin Sales, 2016-2021
5.3.2 By Application - China Crude Heparin Sales, 2022-2027
5.3.3 By Application - China Crude Heparin Sales Market Share, 2016-2027
5.4 By Application - China Crude Heparin Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Bioiberica
6.1.1 Bioiberica Corporation Information
6.1.2 Bioiberica Overview
6.1.3 Bioiberica Crude Heparin Sales and Revenue in China Market (2016-2021)
6.1.4 Bioiberica Crude Heparin Product Description
6.1.5 Bioiberica Recent Developments
6.2 Shenzhen Hepalink
6.2.1 Shenzhen Hepalink Corporation Information
6.2.2 Shenzhen Hepalink Overview
6.2.3 Shenzhen Hepalink Crude Heparin Sales and Revenue in China Market (2016-2021)
6.2.4 Shenzhen Hepalink Crude Heparin Product Description
6.2.5 Shenzhen Hepalink Recent Developments
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Overview
6.3.3 Sanofi Crude Heparin Sales and Revenue in China Market (2016-2021)
6.3.4 Sanofi Crude Heparin Product Description
6.3.5 Sanofi Recent Developments
6.4 Nanjing King-friend
6.4.1 Nanjing King-friend Corporation Information
6.4.2 Nanjing King-friend Overview
6.4.3 Nanjing King-friend Crude Heparin Sales and Revenue in China Market (2016-2021)
6.4.4 Nanjing King-friend Crude Heparin Product Description
6.4.5 Nanjing King-friend Recent Developments
6.5 Fengrun Biological Technology
6.5.1 Fengrun Biological Technology Corporation Information
6.5.2 Fengrun Biological Technology Overview
6.5.3 Fengrun Biological Technology Crude Heparin Sales and Revenue in China Market (2016-2021)
6.5.4 Fengrun Biological Technology Crude Heparin Product Description
6.5.5 Fengrun Biological Technology Recent Developments
6.6 Aspen Oss
6.6.1 Aspen Oss Corporation Information
6.6.2 Aspen Oss Overview
6.6.3 Aspen Oss Crude Heparin Sales and Revenue in China Market (2016-2021)
6.6.4 Aspen Oss Crude Heparin Product Description
6.6.5 Aspen Oss Recent Developments
6.7 Hebei Changshan Biochemical
6.7.1 Hebei Changshan Biochemical Corporation Information
6.7.2 Hebei Changshan Biochemical Overview
6.7.3 Hebei Changshan Biochemical Crude Heparin Sales and Revenue in China Market (2016-2021)
6.7.4 Hebei Changshan Biochemical Crude Heparin Product Description
6.7.5 Hebei Changshan Biochemical Recent Developments
6.8 Changzhou Qianhong
6.8.1 Changzhou Qianhong Corporation Information
6.8.2 Changzhou Qianhong Overview
6.8.3 Changzhou Qianhong Crude Heparin Sales and Revenue in China Market (2016-2021)
6.8.4 Changzhou Qianhong Crude Heparin Product Description
6.8.5 Changzhou Qianhong Recent Developments
6.9 Hepac (Darling Ingredients)
6.9.1 Hepac (Darling Ingredients) Corporation Information
6.9.2 Hepac (Darling Ingredients) Overview
6.9.3 Hepac (Darling Ingredients) Crude Heparin Sales and Revenue in China Market (2016-2021)
6.9.4 Hepac (Darling Ingredients) Crude Heparin Product Description
6.9.5 Hepac (Darling Ingredients) Recent Developments
6.10 Huaian MDC Pharmaceutical
6.10.1 Huaian MDC Pharmaceutical Corporation Information
6.10.2 Huaian MDC Pharmaceutical Overview
6.10.3 Huaian MDC Pharmaceutical Crude Heparin Sales and Revenue in China Market (2016-2021)
6.10.4 Huaian MDC Pharmaceutical Crude Heparin Product Description
6.10.5 Huaian MDC Pharmaceutical Recent Developments
6.11 Yantai Dongcheng Biochemicals
6.11.1 Yantai Dongcheng Biochemicals Corporation Information
6.11.2 Yantai Dongcheng Biochemicals Overview
6.11.3 Yantai Dongcheng Biochemicals Crude Heparin Sales and Revenue in China Market (2016-2021)
6.11.4 Yantai Dongcheng Biochemicals Crude Heparin Product Description
6.11.5 Yantai Dongcheng Biochemicals Recent Developments
7 China Crude Heparin Production Capacity, Analysis
7.1 China Crude Heparin Production Capacity, 2016-2027
7.2 Crude Heparin Production Capacity of Key Manufacturers in China Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Crude Heparin Supply Chain Analysis
9.1 Crude Heparin Industry Value Chain
9.2 Crude Heparin Upstream Market
9.3 Crude Heparin Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Crude Heparin Distributors and Sales Agents in China Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
1.1 Crude Heparin Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Crude Heparin Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Crude Heparin Overall Market Size
2.1 China Crude Heparin Market Size: 2021 VS 2027
2.2 China Crude Heparin Revenue, Prospects & Forecasts: 2016-2027
2.3 China Crude Heparin Sales: 2016-2027
3 Company Landscape
3.1 Top Crude Heparin Players in China Market
3.2 Top China Crude Heparin Companies Ranked by Revenue
3.3 China Crude Heparin Revenue by Companies
3.4 China Crude Heparin Sales by Companies
3.5 China Crude Heparin Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Crude Heparin Companies in China Market, by Revenue in 2020
3.7 Manufacturers Crude Heparin Product Type
3.8 Tier 1, Tier 2 and Tier 3 Crude Heparin Players in China Market
3.8.1 List of Tier 1 Crude Heparin Companies in China
3.8.2 List of Tier 2 and Tier 3 Crude Heparin Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Crude Heparin Market Size Markets, 2021 & 2027
4.1.2 Pig Intestine Mucosa Heparin
4.1.3 Bovine Heparin and Others
4.2 By Type - China Crude Heparin Revenue & Forecasts
4.2.1 By Type - China Crude Heparin Revenue, 2016-2021
4.2.2 By Type - China Crude Heparin Revenue, 2022-2027
4.2.3 By Type - China Crude Heparin Revenue Market Share, 2016-2027
4.3 By Type - China Crude Heparin Sales & Forecasts
4.3.1 By Type - China Crude Heparin Sales, 2016-2021
4.3.2 By Type - China Crude Heparin Sales, 2022-2027
4.3.3 By Type - China Crude Heparin Sales Market Share, 2016-2027
4.4 By Type - China Crude Heparin Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Crude Heparin Market Size, 2021 & 2027
5.1.2 Unfractionated Heparin (UFH)
5.1.3 Low-Molecular-Weight Heparin (LMWH)
5.2 By Application - China Crude Heparin Revenue & Forecasts
5.2.1 By Application - China Crude Heparin Revenue, 2016-2021
5.2.2 By Application - China Crude Heparin Revenue, 2022-2027
5.2.3 By Application - China Crude Heparin Revenue Market Share, 2016-2027
5.3 By Application - China Crude Heparin Sales & Forecasts
5.3.1 By Application - China Crude Heparin Sales, 2016-2021
5.3.2 By Application - China Crude Heparin Sales, 2022-2027
5.3.3 By Application - China Crude Heparin Sales Market Share, 2016-2027
5.4 By Application - China Crude Heparin Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Bioiberica
6.1.1 Bioiberica Corporation Information
6.1.2 Bioiberica Overview
6.1.3 Bioiberica Crude Heparin Sales and Revenue in China Market (2016-2021)
6.1.4 Bioiberica Crude Heparin Product Description
6.1.5 Bioiberica Recent Developments
6.2 Shenzhen Hepalink
6.2.1 Shenzhen Hepalink Corporation Information
6.2.2 Shenzhen Hepalink Overview
6.2.3 Shenzhen Hepalink Crude Heparin Sales and Revenue in China Market (2016-2021)
6.2.4 Shenzhen Hepalink Crude Heparin Product Description
6.2.5 Shenzhen Hepalink Recent Developments
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Overview
6.3.3 Sanofi Crude Heparin Sales and Revenue in China Market (2016-2021)
6.3.4 Sanofi Crude Heparin Product Description
6.3.5 Sanofi Recent Developments
6.4 Nanjing King-friend
6.4.1 Nanjing King-friend Corporation Information
6.4.2 Nanjing King-friend Overview
6.4.3 Nanjing King-friend Crude Heparin Sales and Revenue in China Market (2016-2021)
6.4.4 Nanjing King-friend Crude Heparin Product Description
6.4.5 Nanjing King-friend Recent Developments
6.5 Fengrun Biological Technology
6.5.1 Fengrun Biological Technology Corporation Information
6.5.2 Fengrun Biological Technology Overview
6.5.3 Fengrun Biological Technology Crude Heparin Sales and Revenue in China Market (2016-2021)
6.5.4 Fengrun Biological Technology Crude Heparin Product Description
6.5.5 Fengrun Biological Technology Recent Developments
6.6 Aspen Oss
6.6.1 Aspen Oss Corporation Information
6.6.2 Aspen Oss Overview
6.6.3 Aspen Oss Crude Heparin Sales and Revenue in China Market (2016-2021)
6.6.4 Aspen Oss Crude Heparin Product Description
6.6.5 Aspen Oss Recent Developments
6.7 Hebei Changshan Biochemical
6.7.1 Hebei Changshan Biochemical Corporation Information
6.7.2 Hebei Changshan Biochemical Overview
6.7.3 Hebei Changshan Biochemical Crude Heparin Sales and Revenue in China Market (2016-2021)
6.7.4 Hebei Changshan Biochemical Crude Heparin Product Description
6.7.5 Hebei Changshan Biochemical Recent Developments
6.8 Changzhou Qianhong
6.8.1 Changzhou Qianhong Corporation Information
6.8.2 Changzhou Qianhong Overview
6.8.3 Changzhou Qianhong Crude Heparin Sales and Revenue in China Market (2016-2021)
6.8.4 Changzhou Qianhong Crude Heparin Product Description
6.8.5 Changzhou Qianhong Recent Developments
6.9 Hepac (Darling Ingredients)
6.9.1 Hepac (Darling Ingredients) Corporation Information
6.9.2 Hepac (Darling Ingredients) Overview
6.9.3 Hepac (Darling Ingredients) Crude Heparin Sales and Revenue in China Market (2016-2021)
6.9.4 Hepac (Darling Ingredients) Crude Heparin Product Description
6.9.5 Hepac (Darling Ingredients) Recent Developments
6.10 Huaian MDC Pharmaceutical
6.10.1 Huaian MDC Pharmaceutical Corporation Information
6.10.2 Huaian MDC Pharmaceutical Overview
6.10.3 Huaian MDC Pharmaceutical Crude Heparin Sales and Revenue in China Market (2016-2021)
6.10.4 Huaian MDC Pharmaceutical Crude Heparin Product Description
6.10.5 Huaian MDC Pharmaceutical Recent Developments
6.11 Yantai Dongcheng Biochemicals
6.11.1 Yantai Dongcheng Biochemicals Corporation Information
6.11.2 Yantai Dongcheng Biochemicals Overview
6.11.3 Yantai Dongcheng Biochemicals Crude Heparin Sales and Revenue in China Market (2016-2021)
6.11.4 Yantai Dongcheng Biochemicals Crude Heparin Product Description
6.11.5 Yantai Dongcheng Biochemicals Recent Developments
7 China Crude Heparin Production Capacity, Analysis
7.1 China Crude Heparin Production Capacity, 2016-2027
7.2 Crude Heparin Production Capacity of Key Manufacturers in China Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Crude Heparin Supply Chain Analysis
9.1 Crude Heparin Industry Value Chain
9.2 Crude Heparin Upstream Market
9.3 Crude Heparin Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Crude Heparin Distributors and Sales Agents in China Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
Research Methodology
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analysing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.